| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.07 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.059 | 0.07 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.058 | 0.07 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.08 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.08 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.08 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.068 | 0.08 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.08 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.08 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.059 | 0.08 |